Skip to main content
. 2008 Aug;147(4):2107–2120. doi: 10.1104/pp.108.117754

Table II.

Metabolites accumulating to higher levels in tt4 seeds than in wild-type (Ler) seeds

Alignment and comparison of Ler and tt4 metabolite profiles revealed 145 differential features (fold change ≥ 2, P ≤ 0.05), of which 59 could be putatively annotated. Quant., Quantifier. PCE, Phenolic choline ester; SC, sinapoylcholine.

No. Compound Annotation Levela Retention Time Quant. Ion ESI-FTICR-MSb (Fraction) No. of Detected Differential Features Experiment 1
Experiment 2
Fold Change −log10 (P) Fold Change −log10 (P)
min m/z
20 4-Hydroxybenzoylcholine 1c 10.1 165.05 4 3.9 2.2 6.5 3.4
T21 4-Hexosyloxybenzoylcholine 2d 7.0 386.18 I 6 16.4 2.6 29.0 2.9
T22 4-Hexosyloxycinnamoylcholine isomer 1 2d 8.1 412.20 I 2 n.d. in Ler n.d. in Ler
T23 4-Hexosyloxycinnamoylcholine isomer 2 2d 9.5 412.20 I 0 n.d. in Ler n.d. in Ler
T24 3-(4-Hexosyloxyphenyl)propanoylcholine 2d 9.0 414.21 I 1 n.d. in Ler n.d. in Ler
T25 Unknown PCE 1 3 18.1 504.18 2 13.7 1.9 28.2 2.2
T26 Unknown PCE 2 3 19.7 534.23 I 1 n.d. in Ler n.d. in Ler
T27 Unknown PCE 3 3 24.3 370.19 I 2 44.6 4.6 43.0 3.1
T28 Unknown PCE 4 3 26.8 548.25 I 1 n.d. in Ler n.d. in Ler
T29 Unknown PCE 5 3 37.8 516.22 I 2 5.6 4.2 7.1 5.4
T30 SC dimer isomer 1 3 10.5 310.17 3 22.8 3.0 51.3 3.4
T31 SC dimer isomer 2 3 27.5 310.17 9 21.1 5.7 34.9 4.8
T32 SC dehydro dimer isomer 1 3 21.0 279.62 4 9.8 4.1 24.5 3.3
T33 SC dehydro dimer isomer 2 3 25.9 309.16 7 15.5 5.1 33.4 4.5
T34 9-(Methylsulfinyl)nonanenitrile 2e 32.5 202.13 III 5 7.5 8.9 7.7 4.7
T35 8-(Methylsulfinyl)octanenitrile 2f 26.2 188.11 1 6.3 4.6 6.1 3.4
T36 9-(Methylsulfinyl)nonanoic acid 1c 29.5 203.11 5 11.8 5.9 9.0 5.5
T37 8-(Methylsulfinyl)octane-1-amine 1c 8.9 192.14 1 2.3 1.5 10.1 3.3
38 Indole-3-carbaldehyde 1g 31.1 146.06 2 7.6 5.5 4.7 4.5
a

Annotation level according to Sumner et al. (2007).

b

Elemental composition confirmed by direct infusion ESI-FTICR-MS after fractionation. For numbering of fractions, see “Materials and Methods.”

c

Compound identified with a chemically synthesized standard.

d

Aglycone putatively annotated with a chemically synthesized standard.

e

Compound described in the literature.

f

Compound putatively annotated by interpretation and comparison of CID mass spectra of similar known compounds.

g

Compound identified with a commercially available standard.